Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Opioids
Marketing
Indivior-backed paper spotlights rapid opioid reversal meds
Indivior shared the publication on Fentanyl Awareness Day, touting its Opvee as an overdose reversal med that aligns with the paper’s recommendations.
Andrea Park
Apr 29, 2025 9:30am
Troubled Mallinckrodt, Endo telegraph $6.7B merger plans
Mar 13, 2025 10:18am
FDA signs off on Vertex's non-opioid pain reliever Journavx
Jan 30, 2025 9:22pm
Vertex survey delves into current difficulties in pain treatment
Oct 10, 2024 10:25am
Purdue Pharma snags nod for new overdose-reversal injection
Aug 9, 2024 9:35am
BMJ report digs into Mallinckrodt's opioid selling tactics
Jun 10, 2024 6:30pm